Want to see JP:4438 full AI Analyst Report?
4438 Stock Chart & Stats
¥279.00
¥1.00(0.29%)
At close: 4:00 PM EST
¥279.00
¥1.00(0.29%)
Day’s Range― - ―
52-Week Range¥241.00 - ¥558.00
Previous CloseN/A
Volume4.50K
Average Volume (3M)3.91K
Market Cap
¥2.03B
Enterprise Value¥2.17B
Total Cash (Recent Filing)¥567.83M
Total Debt (Recent Filing)¥235.00M
Price to Earnings (P/E)―
Beta1.14
Next Earnings
Aug 12, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-90.03
Shares Outstanding8,435,582
10 Day Avg. Volume3,070
30 Day Avg. Volume3,910
Financial Highlights & Ratios
PEG Ratio0.13
Price to Book (P/B)8.48
Price to Sales (P/S)3.63
P/FCF Ratio-6.95
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
High Gross MarginsSustained ~71% gross margins indicate strong unit economics and pricing power in healthcare information services. High gross margin provides a structural cushion to fund R&D and sales, improving the company's ability to reach operating breakeven as revenue scales and enabling durable margin support.
2025 Revenue ReboundA ~78% revenue rebound in 2025 after 2024 weakness signals restored customer demand and commercial traction. Durable top-line recovery reduces execution risk and improves prospects for operating leverage, allowing fixed costs to be spread over a larger base if management sustains growth.
Positive Revenue Growth TrendReported revenue growth (~18.86%) indicates multi-period expansion and underlying market demand for the firm's services. Consistent mid-to-high teens growth, combined with strong gross margins, supports scalability and increases the chance to convert sales into profit as operating expenses stabilize.
Bears Say
Negative Free Cash FlowConsistent negative operating cash flow and free cash flow in 2025 reflect ongoing cash burn. Structural cash consumption forces reliance on external financing, raising dilution and refinancing risk, and limits the company's ability to self-fund growth or sustain operations without fresh capital.
Elevated LeverageMaterial increase in debt to ~¥606m and debt-to-equity ~2.22x weakens the balance sheet. Elevated leverage raises fixed interest costs, reduces financial flexibility for investments or downturns, and heightens solvency and covenant risk if revenue or margins deteriorate.
Deep Net LossesVery large net loss (net margin ~-85%) and ongoing negative operating profit show the company fails to convert strong gross margins into profitability. Structural operating deficits point to an entrenched cost base or insufficient scale, requiring significant cost reduction or sustained revenue acceleration.
4438 FAQ
What was Welby Inc.’s price range in the past 12 months?
Welby Inc. lowest stock price was ¥241.00 and its highest was ¥558.00 in the past 12 months.
What is Welby Inc.’s market cap?
Welby Inc.’s market cap is ¥2.03B.
When is Welby Inc.’s upcoming earnings report date?
Welby Inc.’s upcoming earnings report date is Aug 12, 2026 which is in 43 days.
How were Welby Inc.’s earnings last quarter?
Welby Inc. released its earnings results on May 15, 2026. The company reported -¥18.41 earnings per share for the quarter, missing the consensus estimate of N/A by -¥18.41.
Is Welby Inc. overvalued?
According to Wall Street analysts Welby Inc.’s price is currently Overvalued.
Does Welby Inc. pay dividends?
Welby Inc. does not currently pay dividends.
What is Welby Inc.’s EPS estimate?
Welby Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Welby Inc. have?
Welby Inc. has 8,435,582 shares outstanding.
What happened to Welby Inc.’s price movement after its last earnings report?
Welby Inc. reported an EPS of -¥18.41 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -3.051%.
Which hedge fund is a major shareholder of Welby Inc.?
Currently, no hedge funds are holding shares in JP:4438
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Welby Inc.
Established in Tokyo, Japan, in 2011, Welby Inc. specializes in developing digital healthcare solutions aimed at enhancing patients' access to and engagement with medical services. The company's extensive portfolio addresses a wide array of health conditions, encompassing diabetes mellitus, lifestyle-related diseases, mental health disorders, autoimmune and neurological diseases, rare conditions, oncology, and pain management. Furthermore, Welby is active in medical data surveying and operates its signature platform, Welby My Carte.